Shopping Cart 0
Cart Subtotal
AED 0

University of Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

University of Zurich (UZH) is an educational and research university that provides bachelor, master and doctorate programs. The university offers courses in the areas of theology, law, business, economics and informatics, medicine, veterinary medicine, arts and social sciences. Its research activities include national, academic, clinical and faculty priorities. UZH provides libraries which include main library university of Zurich and Zurich central library. The university also offers counseling centers for students, study and course selection. It works in cooperation with national and international committees and organizations including League of European Research Universities, European University Association, and International Association of Universities, among others. UZH is headquartered in Zurich, Switzerland.

University of Zurich-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of Zurich, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

OGD2 Pharma Enters into Partnership Agreement with University Hospital Zurich 10

Licensing Agreements 11

The Geneva Biotech Enters into Licensing Agreement with University of Zurich 11

Viventia Bio Enters into Licensing Agreement with University of Zurich 12

Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 13

Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 14

Neuway Pharma Enters into Licensing Agreement with University of Zurich 15

Equity Offering 16

ImmunOs Therapeutics Spin Out from University of Zurich and University of Basel 16

Myosotis Therapeutics Spin Out from University of Zurich and Charity University Medicine 17

University of Zurich-Key Competitors 18

University of Zurich-Key Employees 19

University of Zurich-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 20

Recent Developments 21

Government and Public Interest 21

Sep 10, 2018: Special Antibodies Could Lead to HIV Vaccine 21

Aug 13, 2018: New approach to treating chronic itch 22

Apr 03, 2018: Scripps Research discovery paves way for better flu prevention, treatment 23

Mar 26, 2018: New Method Speeds Up Development of Medication 24

Jan 31, 2018: University of Zurich: Stealth Virus for Cancer Therapy 25

Jan 31, 2018: Stealth virus for cancer therapy 26

May 30, 2017: Better treatment for kidney cancer thanks to new mouse model 27

Apr 04, 2017: Common antibiotic may help to prevent or treat PTSD 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

University of Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

University of Zurich, Pharmaceuticals & Healthcare, Key Facts 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Zurich, Deals By Therapy Area, 2012 to YTD 2018 8

University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

OGD2 Pharma Enters into Partnership Agreement with University Hospital Zurich 10

The Geneva Biotech Enters into Licensing Agreement with University of Zurich 11

Viventia Bio Enters into Licensing Agreement with University of Zurich 12

Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 13

Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 14

Neuway Pharma Enters into Licensing Agreement with University of Zurich 15

ImmunOs Therapeutics Spin Out from University of Zurich and University of Basel 16

Myosotis Therapeutics Spin Out from University of Zurich and Charity University Medicine 17

University of Zurich, Key Competitors 18

University of Zurich, Key Employees 19

University of Zurich, Subsidiaries 20

University of Zurich, Joint Venture 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

University of Zurich, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

University of Zurich (UZH) is an educational and research university that provides bachelor, master and doctorate programs. The university offers courses in the areas of theology, law, business, economics and informatics, medicine, veterinary medicine, arts and social sciences. Its research activities include national, academic, clinical and faculty priorities. UZH provides libraries which include main library university of Zurich and Zurich central library. The university also offers counseling centers for students, study and course selection. It works in cooperation with national and international committees and organizations including League of European Research Universities, European University Association, and International Association of Universities, among others. UZH is headquartered in Zurich, Switzerland.

University of Zurich-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of Zurich, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

OGD2 Pharma Enters into Partnership Agreement with University Hospital Zurich 10

Licensing Agreements 11

The Geneva Biotech Enters into Licensing Agreement with University of Zurich 11

Viventia Bio Enters into Licensing Agreement with University of Zurich 12

Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 13

Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 14

Neuway Pharma Enters into Licensing Agreement with University of Zurich 15

Equity Offering 16

ImmunOs Therapeutics Spin Out from University of Zurich and University of Basel 16

Myosotis Therapeutics Spin Out from University of Zurich and Charity University Medicine 17

University of Zurich-Key Competitors 18

University of Zurich-Key Employees 19

University of Zurich-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 20

Recent Developments 21

Government and Public Interest 21

Sep 10, 2018: Special Antibodies Could Lead to HIV Vaccine 21

Aug 13, 2018: New approach to treating chronic itch 22

Apr 03, 2018: Scripps Research discovery paves way for better flu prevention, treatment 23

Mar 26, 2018: New Method Speeds Up Development of Medication 24

Jan 31, 2018: University of Zurich: Stealth Virus for Cancer Therapy 25

Jan 31, 2018: Stealth virus for cancer therapy 26

May 30, 2017: Better treatment for kidney cancer thanks to new mouse model 27

Apr 04, 2017: Common antibiotic may help to prevent or treat PTSD 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

University of Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

University of Zurich, Pharmaceuticals & Healthcare, Key Facts 2

University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Zurich, Deals By Therapy Area, 2012 to YTD 2018 8

University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

OGD2 Pharma Enters into Partnership Agreement with University Hospital Zurich 10

The Geneva Biotech Enters into Licensing Agreement with University of Zurich 11

Viventia Bio Enters into Licensing Agreement with University of Zurich 12

Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 13

Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 14

Neuway Pharma Enters into Licensing Agreement with University of Zurich 15

ImmunOs Therapeutics Spin Out from University of Zurich and University of Basel 16

Myosotis Therapeutics Spin Out from University of Zurich and Charity University Medicine 17

University of Zurich, Key Competitors 18

University of Zurich, Key Employees 19

University of Zurich, Subsidiaries 20

University of Zurich, Joint Venture 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

University of Zurich, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.